GKB Ophthalmics shareholders unanimously approve all seven AGM resolutions

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • GKB Ophthalmics shareholders unanimously approved all seven resolutions at its 44th AGM on August 25, 2026
  • Key approvals included re-appointments of K.G. Gupta, Cedric Lobo, and Vikram Gupta to the board
  • Promoter group voted 100% in favour across all resolutions, with varying levels of participation
  • Public institutional investors held 90,000 shares but did not cast any votes during the meeting
  • Total shareholder base stood at 2,602 as on the record date of August 18, 2026
powered bylight_fuzz_icon
49188722

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics shareholders unanimously approved all seven resolutions at its 44th Annual General Meeting held on August 25, 2026. The company reported that every resolution passed with 100% support from the votes polled, reflecting strong backing for the board’s governance and financial proposals.

The meeting, chaired by Chairman & Managing Director K.G. Gupta, took place at the company’s registered office in Mapusa, Goa. It commenced at 11:00 am and concluded at 11:25 am. A total of 32 shareholders were present either in person or through proxy, comprising four from the promoter group and 28 from the public category. No shareholders attended via video conferencing.

Governance Approvals

Shareholders approved the adoption of both standalone and consolidated financial statements for the fiscal year ending March 31, 2026. These ordinary resolutions received overwhelming support, with 2,202,809 votes cast in favour out of 2,202,809 polled. Institutional investors held 90,000 shares but did not cast any votes on these items.

Special resolutions were passed to re-appoint senior leadership. Mr. Cedric Lobo was re-appointed as Executive, Non-Independent, Whole Time Director, while Mr. K.G. Gupta was re-appointed as Chairman and Managing Director. Additionally, Mr. Vikram Gupta, who retires by rotation, was re-appointed as a director through an ordinary resolution. All three governance-related resolutions secured 100% approval from the votes cast.

Voting Participation Breakdown

Promoter group participation varied across resolutions. For the adoption of financial statements, promoters polled 2,155,064 votes (83.59% of their holding). However, for Mr. K.G. Gupta’s re-appointment, promoter participation dropped significantly to 650,430 votes (25.23% of holding), though those who voted did so unanimously in favour.

Public non-institutional shareholders showed consistent engagement, polling approximately 47,745 votes on most resolutions. Public institutional shareholders remained inactive throughout the meeting, casting zero votes despite holding a stake.

Resolution Type Votes Polled Votes In Favour Approval Rate
Adoption of Standalone Financials 2,202,809 2,202,809 100%
Adoption of Consolidated Financials 2,202,809 2,202,809 100%
Re-appointment of Vikram Gupta 2,202,809 2,202,809 100%
Re-appointment of Cedric Lobo 2,202,409 2,202,409 100%
Re-appointment of K.G. Gupta 698,175 698,175 100%
Related Party Transaction Limits 44,680 44,680 100%
Subsidiary Office Approval 287,144 287,144 100%

Operational Context

In his address, the Chairman highlighted significant global economic uncertainty affecting the manufacturing sector. He cited geopolitical tensions, changing trade policies, volatile raw material prices, and supply chain disruptions as key challenges for FY26.

Despite these headwinds, management emphasized a focus on improving operational performance and strengthening market position. The company aims to create lasting value for stakeholders amidst a complex macroeconomic environment.

Meeting Details

The company provided remote e-voting facilities from August 22 to August 24, 2026. Shareholders who did not vote remotely could cast their votes via poll at the meeting. As on the record date of August 18, 2026, the company had 2,602 shareholders.

Statutory auditors MSKA & Associates LLP, secretarial auditor Ms. Girija Nagvekar, and internal auditors RRK & Co attended the meeting. Mr. Shivaram Bhat served as the scrutinizer for the voting process. His report confirmed compliance with Section 108 of the Companies Act, 2013, and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
-5.03%-1.14%+1.62%-1.46%-1.46%-1.46%

How will GKB Ophthalmics mitigate the impact of volatile raw material prices and supply chain disruptions on its FY27 production costs?

What specific operational strategies has management outlined to strengthen market position amidst the cited global economic uncertainties?

Why did promoter voting participation drop significantly for K.G. Gupta's re-appointment compared to financial statement approvals, and does this signal any internal governance shifts?

GKB Ophthalmics holds 44th AGM on Aug 25 with no dividend

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

GKB Ophthalmics conducts its 44th AGM on August 25, 2026, in Mapusa, Goa. The company proposes no dividend for FY25-26. Share transfer books close from August 19-25, with e-voting available until August 24.

powered bylight_fuzz_icon
47029430

*this image is generated using AI for illustrative purposes only.

GKB Ophthalmics will hold its 44th Annual General Meeting (AGM) on Tuesday, August 25, 2026, at 11:00 a.m. IST at its registered office in Mapusa, Goa. The company has confirmed that no dividend is proposed for the financial year 2025-26, indicating a strategy to retain capital rather than distribute profits to shareholders during this period. This decision impacts investor returns for the fiscal year ended March 31, 2026.

The Register of Members and Share Transfer Books will remain closed from Wednesday, August 19, 2026, to Tuesday, August 25, 2026, to finalize the list of shareholders eligible for the meeting. Shareholders holding units as of the end of business on Tuesday, August 18, 2026, are entitled to vote. During the closure period, no transfer of shares or registration of new members will be processed.

Key Dates and Details

Event Date
Book Closure Start August 19, 2026
Book Closure End August 25, 2026
44th AGM Date August 25, 2026
Dividend Proposed No

Shareholders can exercise their voting rights through remote e-voting or by attending the AGM in person. The remote e-voting period begins on Saturday, August 22, 2026, at 9:00 a.m. and concludes on Monday, August 24, 2026, at 5:00 p.m. The facility is provided by Central Depository Services (India) Limited (CDSL). Members who have already cast their votes via remote e-voting may attend the meeting but cannot vote again.

Regulatory Compliance and Voting Process

The book closure and AGM proceedings comply with Section 91 of the Companies Act, 2013, and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice for the AGM, along with the Annual Report for FY25-26, was dispatched electronically on Friday, July 31, 2026, to members with registered email addresses. For those without registered emails, a letter containing the web-link to the documents was sent.

Mr. Shivaram Bhat, a practicing Company Secretary (Membership No. 10454), has been appointed as the Scrutinizer to oversee the e-voting process. The results of the voting will be declared within 48 hours of the AGM's conclusion. Members holding shares in physical mode are requested to update their KYC details and email addresses with the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, using Form ISR-1 if they have not done so previously.

Historical Stock Returns for GKB Ophthalmics

1 Day5 Days1 Month6 Months1 Year5 Years
-5.03%-1.14%+1.62%-1.46%-1.46%-1.46%

What specific capital allocation strategies or growth initiatives is GKB Ophthalmics prioritizing with the retained earnings from FY25-26?

How might the decision to forgo dividends impact GKB Ophthalmics' stock valuation and investor sentiment compared to peers in the ophthalmic sector?

Are there any pending regulatory approvals or strategic partnerships that could influence the company's financial outlook in the upcoming fiscal year?

More News on GKB Ophthalmics

Must Read Next

Earnings

Texmaco Rail targets mid-teen EBITDA margin, double revenue by 2030 1 hr ago
Patanjali Foods Latest Results: rural demand, sunflower oil remain weak 1 hr ago
1 Year Returns:-1.46%